Purdue Pharma’s newly created subsidiaries raise questions over attempts to shield assets from bankruptcy
In recent months, Purdue launched two limited partnerships that are marketing or developing drugs previously listed as part of the Purdue product portfolio.
No hay comentarios:
Publicar un comentario